advanced search

Welcome: Guest

log in

Cardiogenesis Corporation Product Pipeline Analysis

Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 30
ISBN Number not applicable
Product Code GMD04675
Price

£490.00
approximately: $749 | €546

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Cardiogenesis Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Overview
    • 2.1 Key Information
    • 2.2 Industry Outlook Cardiovascular Devices
  • 3 Major Products and Services
    • 3.1 Overview
  • 4 Competitors
  • 5 Key Employees
  • 6 Locations And Subsidiaries
    • 6.1 Head Office
  • 7 Recent Developments
    • 7.1 Financial Announcements
      • 7.1.1 Aug 14, 2008: Cardiogenesis Reports 2Q 2008 Results
      • 7.1.2 May 15, 2008: Cardiogenesis Reports Q1 2008 Results
      • 7.1.3 May 01, 2008: Cardiogenesis To Declare Q1 2008 Results
      • 7.1.4 Mar 25, 2008: Cardiogenesis Declares Q4 2007 Results
      • 7.1.5 Mar 06, 2008: Cardiogenesis Reschedules Q4 2007 Results Release
      • 7.1.6 Nov 14, 2007: Cardiogenesis Declares Q3 2007 Results
      • 7.1.7 Aug 14, 2007: Cardiogenesis Declares Q2 2007 Results
      • 7.1.8 May 15, 2007: Cardiogenesis Declares Q1 2007 Results
    • 7.2 Corporate Communications
      • 7.2.1 Jun 20, 2007: Cardiogenesis Elects Chairman
    • 7.3 Product News
      • 7.3.1 May 10, 2007: Cardiogenesis Announces Submission Of PMA Supplement For Minimally Invasive Robotic Delivery System
      • 7.3.2 Dec 12, 2005: PEARL TMR Delivery System Gets CE Mark Approval
    • 7.4 Product Approvals
      • 7.4.1 Dec 12, 2005: PEARL TMR Delivery System Gets CE Mark Approval
  • 8 Cardiogenesis Corporation Pipeline Products
    • 8.1 Cardiogenesis Corporation Product Pipeline Analysis
      • 8.1.1 Cardiogenesis Corporation Pipeline Products By Equipment Type
      • 8.1.2 Cardiogenesis Corporation Pipeline Products By Development Stage
      • 8.1.3 Cardiogenesis Corporation Pipeline Products By Therapy Area
      • 8.1.4 Cardiogenesis Corporation Pipeline Products By News Summary
    • 8.2 PEARL 8.0
      • 8.2.1 Product Description
      • 8.2.2 Product Status
      • 8.2.3 Product Milestone
    • 8.3 PHOENIX Revascularization Delivery System
      • 8.3.1 Product Description
      • 8.3.2 Product Status
      • 8.3.3 Product Milestone
    • 8.4 Axcis PMC Delivery System
      • 8.4.1 Product Description
      • 8.4.2 Product Status
    • 8.5 Axcis Laser Catheter System
      • 8.5.1 Product Description
      • 8.5.2 Product Status
  • 9 Appendix
    • 9.1 Methodology
      • 9.1.1 Coverage
      • 9.1.2 Secondary Research
      • 9.1.3 Primary Research
      • 9.1.4 Expert Panel Validation
    • 9.2 Contact Us
    • 9.3 About Global Markets Direct
    • 9.4 Disclaimer
  • 1 List of Tables
    • Table 1: Cardiogenesis Corporation,Key Facts
    • Table 2: Cardiogenesis Corporation, Key Employees,
    • Table 3: Cardiogenesis Corporation Pipeline Products by Equipment Type
    • Table 4: Cardiogenesis Corporation Pipeline Products By Development Stage
    • Table 5: Cardiogenesis Corporation Pipeline Products By Therapy Area
    • Table 6: Cardiogenesis Corporation Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: Cardiogenesis Corporation Pipeline Products By Development Stage
    • Figure 2: Global Markets Direct Methodology